BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 17601572)

  • 1. Destruction of the orbit and globe by recurrence of basal cell carcinoma.
    Chew R
    Optometry; 2007 Jul; 78(7):344-51. PubMed ID: 17601572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Globe-sparing surgery for medial canthal Basal cell carcinoma with anterior orbital invasion.
    Madge SN; Khine AA; Thaller VT; Davis G; Malhotra R; McNab A; O'Donnell B; Selva D
    Ophthalmology; 2010 Nov; 117(11):2222-8. PubMed ID: 20570356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subconjunctival "ring" recurrence of Basal cell carcinoma of the globe.
    Lee S; Cnaan RB; Paramanathan N; Davies M; Benger R; Ghabrial R
    Ophthalmic Plast Reconstr Surg; 2010; 26(2):117-8. PubMed ID: 20305512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for orbital exenteration in periocular Basal cell carcinoma.
    Iuliano A; Strianese D; Uccello G; Diplomatico A; Tebaldi S; Bonavolontà G
    Am J Ophthalmol; 2012 Feb; 153(2):238-241.e1. PubMed ID: 21982108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orbital invasion by periocular basal cell carcinoma.
    Leibovitch I; McNab A; Sullivan T; Davis G; Selva D
    Ophthalmology; 2005 Apr; 112(4):717-23. PubMed ID: 15808267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal cell carcinoma of the eyelids and periorbital region in a Turkish population.
    Soysal HG; Soysal E; Markoç F; Ardiç F
    Ophthalmic Plast Reconstr Surg; 2008; 24(3):201-6. PubMed ID: 18520835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supraestructure maxillectomy and orbital exenteration for treatment of basal cell carcinoma of inferior eyelid: case report and review.
    Villalon-Lopez JS; Valle-Mejia CA; Patino-Lara A; Moreno-Perez BA; Munoz-Lopez JA; Alcantar-Andrade A
    J Cancer Res Ther; 2006; 2(3):140-3. PubMed ID: 17998694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent sebaceous gland carcinoma of eyelid previously diagnosed as basal cell carcinoma: case report.
    Kan LW; Leu YS; Tzen CY; Wu CH
    Am J Otolaryngol; 2011; 32(6):620-3. PubMed ID: 21168242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent eyelid basal cell carcinoma with sclerochoroidal infiltration: echographic findings.
    Mantovani E; Doro D; Milizia E; Steindler P
    Ophthalmologica; 1998; 212 Suppl 1():40-1. PubMed ID: 9730747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal cell carcinoma of the medial canthus. Its orbital implications.
    Wiggs EO
    Mod Probl Ophthalmol; 1975; 14():549-52. PubMed ID: 1177923
    [No Abstract]   [Full Text] [Related]  

  • 11. The significance of positive margins (known and unknown) at the conclusion of Mohs surgery in the orbital region.
    Boynton JR; Rounds MF; Quatela VC; Brown MD
    Ophthalmic Plast Reconstr Surg; 1996 Mar; 12(1):51-7. PubMed ID: 8652459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensive destruction of the eyeball by invasion of basal cell carcinoma of the eyelid.
    Jeong S; Yang KJ; Park YG
    Jpn J Ophthalmol; 1999; 43(4):300-2. PubMed ID: 10482476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic safety margins of periocular BCC.
    Rumelt S
    Ophthalmology; 2010 Feb; 117(2):403-4; author reply 404. PubMed ID: 20141864
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term results after treatment of basal cell carcinoma of the eyelid in South-Western Finland.
    Paavilainen V; Tuominen J; Aho VV; Saari KM
    Eur J Ophthalmol; 2007; 17(4):494-500. PubMed ID: 17671921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eyelid basal cell carcinoma: non-Mohs excision, repair, and outcome.
    Hamada S; Kersey T; Thaller VT
    Br J Ophthalmol; 2005 Aug; 89(8):992-4. PubMed ID: 16024851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary basosquamous carcinoma of the lower eyelid with ocular invasion A case report.
    Papadopoulos GO; Charitonidi E; Filippou N; Fanidou D; Filippou D; Scandalakis P
    Ann Ital Chir; 2018 Mar; 7():. PubMed ID: 29626183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up.
    Malhotra R; Huilgol SC; Huynh NT; Selva D
    Ophthalmology; 2004 Apr; 111(4):631-6. PubMed ID: 15051193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic safety margin in basal cell carcinoma of the eyelid: correlation with recurrence rate.
    Auw-Haedrich C; Frick S; Boehringer D; Mittelviefhaus H
    Ophthalmology; 2009 Apr; 116(4):802-6. PubMed ID: 19232734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of periocular basal and squamous cell carcinoma: a series of 485 cases.
    Nemet AY; Deckel Y; Martin PA; Kourt G; Chilov M; Sharma V; Benger R
    Am J Ophthalmol; 2006 Aug; 142(2):293-7. PubMed ID: 16876511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eyelid and ocular surface carcinoma: diagnosis and management.
    Yin VT; Merritt HA; Sniegowski M; Esmaeli B
    Clin Dermatol; 2015; 33(2):159-69. PubMed ID: 25704936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.